Search
The Intriguing Truth About Orthobiologics: Current Uses, Future Possibilities
For healing diseased or damaged tissues, therapies that use the body's native cellular components may have long-term advantages over go-to treatments, such as steroid injections.The Fetal Treatment Center in Oakland: Expanded Services, Informed Strategies - Intro
Learn which patients may benefit from referral and what to expect from the process in this update from perinatologist Annalisa Post, MD.Preeclampsia Update: How to Identify and Manage a Perilous Pregnancy Complication
This important talk from Annalisa Post, MD, a perinatologist with the UCSF Fetal Treatment Center, clarifies the definition of preeclampsia, lays out risk factors, and elucidates the tricky business of recognizing worsening hypertension in pregnancy.Keys to the Knees: How to Approach a Variety of Meniscus Tears
Historically misunderstood even by sports medicine specialists, meniscus tears are a range of conditions best managed by considering specifics of both the injury and the patient.Halt the UTI Cycle: Tips and Techniques for Treating a Common Urinary Woe
Urogynecologist Abigail Shatkin-Margolis, MD, offers an update to help PCPs efficiently assess and treat patients prone to urinary tract infections, with a focus on both young and elderly adults.The Reflux “Cycle of Hell”: An ENT Perspective on Setting Patients Free
When different doctors – PCPs, gastroenterologists and otolaryngologists – take different approaches to the common problem of acid reflux, patients often continue to suffer.A Fresh Look at Lipids: Atherosclerosis Prevention in 2023
Cardiologist Clifton Watt, MD, presents an update on lipoproteins, including how genetic factors can impact test results and whether pre-measurement fasting actually matters.Focused Cancer Updates: Neoadjuvant Therapy for Breast Cancer and Managing Immunotherapy Toxicity
An expert panel delivers news to inform therapy and monitoring decisions, including a look at how the I-SPY 2 trial is accelerating evaluation of promising agents in high-risk breast cancer.The UCSF Hip Preservation Center: Where Hurting Hips Go to Become Happy Hips
See how our specialists work together and use advanced techniques to address all types of hip injuries in all types of patients, including infants and athletes.Novel Tricuspid and Mitral Valve Procedures Improve Patients' Quality of Life
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.Prenatal Enzyme Replacement Therapy for Lysosomal Storage Diseases
Pregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.Incidental Thyroid Nodules: Benign Bump or Big Deal?
A lump on the thyroid is a common finding in both physical exams and imaging studies, but the significance varies greatly.Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up
Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.CAR T-Cells for Hematologic Malignancies and Beyond
In this data-drenched discussion, UCSF specialists review how CAR T-cells are being used in hematologic malignancies, including aggressive lymphoma and difficult-to-treat myeloma, as well as for solid tumors, and reveal what's on the horizon with regard to these products.Placenta Accreta Spectrum Disorder: Proven Strategies from a Multidisciplinary Team
Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs.Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer
Upcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer RiskDon’t Miss a Beat on A-fib: How to Make the Right Plans for Individual Patients
This practical, data-fueled talk from Edward P. Gerstenfeld, MD, MS, FACC, chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service, will help PCPs better understand how to assess stroke risk; make treatment decisions...Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics
In this update on inflammatory bowel disease, gastroenterologist Kendall Beck, MD, notes contributing causes, explains which tests have value, gives keys to distinguishing ulcerative colitis and Crohn’s...UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.Keeping the Eye in Sight: Ensure Proper Primary Care for Ocular Injuries
When presented with common eye issues – from corneal abrasions and foreign bodies to potentially fractured orbital bones – providers need to make prompt diagnoses, assess urgency and take steps to limit damage.A Guide to Gout: Keys to Recognizing and Managing This Damaging Disease
Noting that gout is common yet under-recognized and undertreated, rheumatologist Kerstin Morehead, MD, presents a valuable update on risk factors, associated conditions, and treatments for both acute flares and chronic disease.Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.Novel Metabolic Imaging Method Detects Prostate Cancer Aggressiveness
UCSF investigators have shown that adding an emerging metabolic imaging technique to MR–transrectal ultrasound fusion prostate biopsies makes it possible to detect the extent and aggressiveness of prostate cancer more accurately than ever.